Cargando…
Validation of a human-serum-based in vitro growth method for drug screening on juvenile development stages of Schistosoma mansoni
BACKGROUND: Schistosomiasis affects over 200 million people worldwide but only praziquantel is available for treatment and control. Drug discovery is often based on phenotypic drug screening, involving different parasite stages retrieved from infected mice. Aiming to reduce animal use, we validated...
Autores principales: | Buchter, Valentin, Schneeberger, Pierre H. H., Keiser, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034724/ https://www.ncbi.nlm.nih.gov/pubmed/33784302 http://dx.doi.org/10.1371/journal.pntd.0009313 |
Ejemplares similares
-
Assessment of tegumental damage to Schistosoma mansoni and S. haematobium after in vitro exposure to ferrocenyl, ruthenocenyl and benzyl derivatives of oxamniquine using scanning electron microscopy
por: Buchter, Valentin, et al.
Publicado: (2018) -
Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome
por: Schneeberger, Pierre H. H., et al.
Publicado: (2018) -
Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
por: Cowan, Noemi, et al.
Publicado: (2015) -
Naturally Occurring Cardenolides Affecting Schistosoma mansoni
por: Keiser, Jennifer, et al.
Publicado: (2020) -
Screening a repurposing library, the Medicines for Malaria Venture Stasis Box, against Schistosoma mansoni
por: Pasche, Valérian, et al.
Publicado: (2018)